FDA Inspection
Inopak LtdInopak Ltd – FDA Inspection, Feb 11, 2015
Record Details
This FDA Inspection record concerns Inopak Ltd, with an inspection on February 11, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Inopak Ltd
- Inspection Date
- February 11, 2015
- Product Type
- Drugs
View Company Profile
ID · 335a4e40-2af1-417e-a921-3f4a3ba718a7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 913858
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.170(b)Drug product reserve containers
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Inopak Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Inopak Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.